{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:17:17Z","timestamp":1787026637024,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009379","name":"Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung, Universit\u00e4tsklinikum W\u00fcrzburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Autoimmune nodopathy (AN) is a new entity in the field of peripheral neuropathies and is defined by the presence of auto-antibodies against structures of the node of Ranvier combined with specific clinico-pathophysiological features and therapy response in affected patients. The target-specific antibodies do not only serve as diagnostic biomarkers but also for treatment evaluation during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>We report a 66-year-old female patient with various autoimmune diseases, including a history of membranous glomerulonephritis which presented with acute-onset, sensorimotor tetraparesis, cranial nerve involvement, and mild respiratory insufficiency. Under the suspicion of Guillain\u2013Barr\u00e9 syndrome, she received intravenous immunoglobulins (IVIg) and achieved remission. At 8 months later, she relapsed with now a poor response to IVIg and developed additional features such as severe sensory ataxia, tremor, and neuropathic pain. Anti-contactin-1 IgG2 antibodies were detected, and the diagnosis was reverted to AN. Plasma exchange and rituximab treatment led to a serological remission and corresponding significant clinical improvement, and the therapy was paused. At 2 years after symptom onset, her condition worsened again with sensorimotor symptoms and severe neuropathic pain despite seronegativity for contactin-1. However, serum binding assays to teased nerve fiber staining showed recurring antibody reactivity against paranodal structures. Caspr-1 was identified as a new target antigen via cell-based assay, and high-titer antibodies of the IgG4 subclass were confirmed via ELISA. Hence, a new cycle of plasma exchange and regular rituximab treatment was initiated, with subsequent clinical improvement and serological remission. The serum neurofilament light chain (sNFL) levels were assessed retrospectively and rose and fell together with the antibody titer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case demonstrates that autoimmunity to (para)nodal structures can reoccur especially in patients prone to autoimmune disorders and can switch its target antigen and subclass in the course of disease. The presence of auto-antibodies against different targets at the node of Ranvier has direct implications for therapeutic management. We suggest a close follow-up of patients with AN after successful therapy. In case of deterioration despite seronegativity, non-specific tests such as teased fiber assays and repeated screening for different target antigens should be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1475478","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:40:59Z","timestamp":1728261659000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case report: target antigen and subclass switch in a patient with autoimmune nodopathy"],"prefix":"10.3389","volume":"15","author":[{"given":"Luise","family":"Appeltshauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Glenewinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Rohrbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Wessely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Villmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Doppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12455","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J Peripheral Nervous System: JPNS"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001107","article-title":"Autoimmune nodopathies, an emerging diagnostic category","volume":"35","author":"Mart\u00edn-Aguilar","year":"2022","journal-title":"Curr Opin Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183211","DOI":"10.1016\/j.bbamem.2020.183211","article-title":"Molecular organization and function of vertebrate septate-like junctions","volume":"1862","author":"Faivre-Sarrailh","year":"2020","journal-title":"Biochim Biophys Acta Biomembranes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurgery Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain: J Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124694","article-title":"Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"130","author":"Manso","year":"2019","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac418","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage","volume":"146","author":"Appeltshauser","year":"2023","journal-title":"Brain: J Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e16406","DOI":"10.1111\/ene.v31.10","article-title":"Proteinuria is a key to suspect autoimmune nodopathies","volume":"31","author":"Funakoshi","year":"2024","journal-title":"Eur J Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/WCO.0000000000001195","article-title":"Pan-Neurofascin autoimmune nodopathy - a life-threatening, but reversible neuropathy","volume":"36","author":"Appeltshauser","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0281156","DOI":"10.1371\/journal.pone.0281156","article-title":"Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis","volume":"18","author":"Fehmi","year":"2023","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1098","DOI":"10.1212\/NXI.0000000000001098","article-title":"Clinical and laboratory features in anti-NF155 autoimmune nodopathy","volume":"9","author":"Mart\u00edn-Aguilar","year":"2022","journal-title":"Neurol  Neuroimmunol Neuroinflammation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurgery Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0134274","DOI":"10.1371\/journal.pone.0134274","article-title":"Contactin-1 and neurofascin-155\/-186 are not targets of auto-antibodies in multifocal motor neuropathy","volume":"10","author":"Doppler","year":"2015","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000817","article-title":"Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurology(R) Neuroimmunol Neuroinflamm"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurology(R) Neuroimmunol Neuroinflamm"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/ene.v30.12","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"30","author":"Van Doorn","year":"2023","journal-title":"Eur J Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain: J Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain: J Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-328X(94)90372-7","article-title":"Identification and characterization of the human cell adhesion molecule contactin","volume":"21","author":"Reid","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes","volume":"518","author":"Kundaje","year":"2015","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12597-6","article-title":"IgG subclass shifts occurring at acute exacerbations in autoimmune nodopathies","volume":"271","author":"Kokubun","year":"2024","journal-title":"J Neurol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab014","article-title":"Antibodies to the Caspr1\/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"144","author":"Pascual-Go\u00f1i","year":"2021","journal-title":"Brain: J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"577139","DOI":"10.1016\/j.jneuroim.2019.577139","article-title":"Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy","volume":"339","author":"Ogata","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG(1) pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality","volume":"92","author":"Fehmi","year":"2021","journal-title":"J Neurol Neurosurgery Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15428","article-title":"Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies","volume":"29","author":"Kmezic","year":"2022","journal-title":"Eur J Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323899","article-title":"Serum neurofilament light chain predicts long-term prognosis in Guillain-Barr\u00e9 syndrome patients","volume":"92","author":"Mart\u00edn-Aguilar","year":"2020","journal-title":"J Neurol Neurosurgery Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"578326","DOI":"10.1016\/j.jneuroim.2024.578326","article-title":"Low-dose\u00a0rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy","volume":"389","author":"Kmezic","year":"2024","journal-title":"J Neuroimmunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurgery Psychiatry"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1475478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:41:00Z","timestamp":1728261660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1475478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2024.1475478"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1475478","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,7]]},"article-number":"1475478"}}